Application of multiscale algebra and topology to understanding heterogeneity in the immune response to SARS CoV 2 infection

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: EP/W01484X/1

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2021
    2022
  • Known Financial Commitments (USD)

    $233,583.36
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Julian Knight
  • Research Location

    United Kingdom
  • Lead Research Institution

    University of Oxford
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The basis of variability between patients in their immune response and outcome from acute SARS-Cov-2 infection remains poorly defined, limiting opportunities for targetted intervention. The generation of multi-modal molecular and immunological data sets profiling the immune response across individuals and over time provides opportunities to address this but maximising the informativeness of such datasets remains a major roadblock. Here, we propose to address this through application of state-of-the-art integrative mathematical and computational techniques to analyse data together and extract novel insights. We will use algebraic systems biology approaches to combine algebraic geometry, data tensors, topological data analysis and network theory to encode multidimensional and multi-indexed data in order to identify signatures and cellular drivers of heterogeneity in the host immune response leading to different disease severity. We will apply this to data recently generated by the Oxford COVID-19 Multi-Omic Blood ATlas (COMBAT) consortium which includes high resolution clinical phenotyping, single cell profiling of the cellular blood compartment for composition, repertoire, transcriptomics and epigenomics, the plasma secretome, serology, viral sequencing, metagenomics and host genotyping. Our application is timely and urgent given availability of data and opportunity for impact. The work will promote collaboration between medical and mathematical sciences, promoting cross-disciplinarity. The analysis will provide novel insights into pathophysiology, identify key networks and nodal points for targetted intervention that will enable development of immunmodulatory therapy, and define biomarkers informative for the individual immune response that can be taken forward for validation and enable development of a precision medicine approach to COVID-19.